Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries.
Despite the high burden of hyperlipidemia and the effectiveness of treatment, evidence suggests that the accessibility of hyperlipidemia medicines can be low in many low- and middle-income countries (LMICs). The aim of this study was to identify common barriers to the accessibility of medicines for...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Search Result 1